These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
119 related articles for article (PubMed ID: 6981047)
21. Lymphokine production by human T cell hybridomas. Le J; Vilcek J; Sadlik JR; Cheung MK; Balazs I; Sarngadharan MG; Prensky W J Immunol; 1983 Mar; 130(3):1231-5. PubMed ID: 6401782 [TBL] [Abstract][Full Text] [Related]
22. Human peripheral blood monocytes release a 30,000 dalton factor (30 KD MF) that stimulates immunoglobulin production by activated B cells. Rossen RD; Laughter AH; Orson FM; Flagge FP; Cashaw JL; Sumaya CV J Immunol; 1985 Nov; 135(5):3289-97. PubMed ID: 3930602 [TBL] [Abstract][Full Text] [Related]
23. Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS. Mizel SB; Oppenheim JJ; Rosentreich DL J Immunol; 1978 May; 120(5):1504-8. PubMed ID: 307016 [TBL] [Abstract][Full Text] [Related]
24. Suppression of a pokeweed mitogen-stimulated plaque-forming cell response by a human B lymphocyte-derived aggregated IgG-stimulated suppressor factor: suppressive B cell factor (SBF). Pisko EJ; Foster SL; White RE; Panetti M; Turner RA J Immunol; 1986 Mar; 136(6):2141-50. PubMed ID: 2419423 [TBL] [Abstract][Full Text] [Related]
25. Monoclonal antibody against human interleukin 2 (IL 2). I. Purification of IL 2 for the production of monoclonal antibodies. Stadler BM; Berenstein EH; Siraganian RP; Oppenheim JJ J Immunol; 1982 Apr; 128(4):1620-4. PubMed ID: 6977565 [TBL] [Abstract][Full Text] [Related]
26. Identification and characterization of a B cell growth inhibitory factor (BIF) on BCGF-dependent B cell proliferation. Kawano M; Iwato K; Kuramoto A J Immunol; 1985 Jan; 134(1):375-81. PubMed ID: 3871108 [TBL] [Abstract][Full Text] [Related]
27. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines. Gillis S; Smith KA; Watson J J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967 [TBL] [Abstract][Full Text] [Related]
28. Biochemical characterization of regulatory factors derived from T cell hybridomas and spleen cells. II. Evidence for glycosylation of T cell growth factor, T cell replacing factor, and granulocyte-macrophage colony-stimulating factor. Clark-Lewis I; Schrader JW J Immunol; 1982 Jan; 128(1):175-80. PubMed ID: 6976370 [TBL] [Abstract][Full Text] [Related]
29. Lymphokines: their role in lymphocyte responses. Properties of interleukin 1. Oppenheim JJ; Stadler BM; Siraganian RP; Mage M; Mathieson B Fed Proc; 1982 Feb; 41(2):257-62. PubMed ID: 6800841 [TBL] [Abstract][Full Text] [Related]
30. Stimulators and inhibitors of lymphocyte DNA synthesis in supernatants from human lymphoid cell lines. Vesole DH; Goust JM; Fett JW; Fudenberg HH J Immunol; 1979 Sep; 123(3):1322-8. PubMed ID: 313950 [TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of a monoclonal nonspecific suppressor factor (MNSF) produced by a T cell hybridoma. Nakamura M; Ogawa H; Tsunematsu T J Immunol; 1986 Apr; 136(8):2904-9. PubMed ID: 2420877 [TBL] [Abstract][Full Text] [Related]
32. Monocyte procoagulant inducing factor: a lymphokine involved in the T cell-instructed monocyte procoagulant response to antigen. Gregory SA; Kornbluth RS; Helin H; Remold HG; Edgington TS J Immunol; 1986 Nov; 137(10):3231-9. PubMed ID: 2945864 [TBL] [Abstract][Full Text] [Related]
33. Functional characteristics of histamine receptor-bearing mononuclear cells. I. Selective production of lymphocyte chemoattractant lymphokines with histamine used as a ligand. Center DM; Cruikshank WW; Berman JS; Beer DJ J Immunol; 1983 Oct; 131(4):1854-9. PubMed ID: 6352807 [TBL] [Abstract][Full Text] [Related]
34. Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones. Kasahara T; Mukaida N; Hatake K; Motoyoshi K; Kawai T; Shiori-Nakano K J Immunol; 1985 Mar; 134(3):1682-9. PubMed ID: 3871456 [TBL] [Abstract][Full Text] [Related]
35. Activity and molecular properties of mitogenic factors produced by mixed lymphocyte reactions (MLC-MF) in humans and guinea pigs. de Weck AL; Otz U; Geczy C; Geczy AF Transplant Proc; 1979 Jun; 11(2):1387-9. PubMed ID: 157577 [No Abstract] [Full Text] [Related]
36. Isolation and characterization of lymphocyte mitogenic factor released in vivo during a cell-mediated immune reaction in the guinea pig. Postlethwaite AE J Immunol; 1980 Nov; 125(5):1955-8. PubMed ID: 6968767 [TBL] [Abstract][Full Text] [Related]
37. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas. Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737 [TBL] [Abstract][Full Text] [Related]
38. Purification and physicochemical characterization of murine T cell replacing factor (TRF). Takatsu K; Harada N; Hara Y; Takahama Y; Yamada G; Dobashi K; Hamaoka T J Immunol; 1985 Jan; 134(1):382-9. PubMed ID: 3871109 [TBL] [Abstract][Full Text] [Related]
39. Human suppressor factors constitutively produced by T-T cell hybridomas: functional and biochemical characterization. Kunicka JE; Calvelli TA; Fox FE; Steinberg J; Telerman A; Platsoucas C Hybridoma; 1989 Apr; 8(2):127-51. PubMed ID: 2785481 [TBL] [Abstract][Full Text] [Related]
40. Constitutive production of a factor supporting B lymphocyte differentiation by a T cell hybridoma. Elkins K; Cambier JC J Immunol; 1983 Mar; 130(3):1247-51. PubMed ID: 6337214 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]